Literature DB >> 3355562

The effect of inosine on the post ischemic heart as bio-energy recovering factor in 31P-MRS.

M Yoshiyama1, H Sakai, M Teragaki, K Takeuchi, T Takeda, M Ikata, M Ishikawa, I Miura.   

Abstract

Perfused guinea-pig hearts, which were analyzed by 31P-MRS, were subjected to 30 and 60 minute ischemia and reperfused using two perfusates, one containing 200 microM inosine, and the other without inosine. After 4 hour reperfusion with inosine, ATP levels increased to 95.5% of preischemic value (30 minute ischemia) and 76.2% (60 minute ischemia). However, after 4 hour reperfusion without inosine, ATP levels increased only to 72.2% (30 minute ischemia) and to 48.2% (60 minute ischemia). In 60 minute ischemic hearts reperfused with inosine, left ventricular maximal positive dp/dt (LV dp/dt) was improved significantly to 82.4% after 6 hour reperfusion in contrast to hearts reperfused without inosine (43.1%). Administration of inosine was very useful for increasing myocardial gross energy product and improving cardiac performance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3355562     DOI: 10.1016/s0006-291x(88)80519-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Demonstration of adenosine deaminase activity in human fibroblast lysosomes.

Authors:  E R Lindley; R L Pisoni
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

2.  Effects of inosine on reperfusion injury after cardiopulmonary bypass.

Authors:  Gábor Veres; Tamás Radovits; Leila Seres; Ferenc Horkay; Matthias Karck; Gábor Szabó
Journal:  J Cardiothorac Surg       Date:  2010-11-08       Impact factor: 1.637

3.  The influence of calcium antagonists on the adenine nucleotide metabolism in the guinea-pig working heart during ischaemia and reperfusion.

Authors:  J G Hugtenburg; M J Mathy; N de Haan; J J Beckeringh; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-05       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.